News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
621,285 Results
Type
Article (49758)
Company Profile (191)
Press Release (571336)
Section
Business (171023)
Career Advice (2005)
Deals (30346)
Drug Delivery (102)
Drug Development (75465)
Employer Resources (149)
FDA (16272)
Job Trends (13672)
News (299784)
Policy (29827)
Tag
Academia (2712)
Alliances (44843)
Alzheimer's disease (1289)
Approvals (16251)
Artificial intelligence (226)
Bankruptcy (261)
Best Places to Work (11014)
Biotechnology (126)
Breast cancer (228)
Cancer (1794)
Cardiovascular disease (138)
Career advice (1679)
CAR-T (130)
Cell therapy (362)
Clinical research (61149)
Collaboration (673)
Compensation (248)
COVID-19 (2622)
C-suite (164)
Data (1656)
Diabetes (213)
Diagnostics (5949)
Earnings (63633)
Employer resources (134)
Events (88728)
Executive appointments (543)
FDA (17236)
Funding (608)
Gene therapy (256)
GLP-1 (673)
Government (4413)
Healthcare (18546)
Infectious disease (2737)
Inflammatory bowel disease (131)
Interviews (331)
IPO (14010)
Job creations (3096)
Job search strategy (1441)
Layoffs (382)
Legal (6222)
Lung cancer (268)
Manufacturing (230)
Medical device (14188)
Medtech (14192)
Mergers & acquisitions (16721)
Metabolic disorders (577)
Neuroscience (1713)
NextGen: Class of 2025 (6529)
Non-profit (4492)
Northern California (1902)
Obesity (319)
Opinion (235)
Patents (155)
People (50722)
Phase I (18520)
Phase II (27052)
Phase III (20624)
Pipeline (764)
Postmarket research (2381)
Preclinical (7462)
Radiopharmaceuticals (264)
Rare diseases (350)
Real estate (5108)
Regulatory (20995)
Research institute (2434)
Resumes & cover letters (316)
Southern California (1661)
Startups (3663)
United States (17433)
Vaccines (643)
Weight loss (234)
Date
Today (73)
Last 7 days (716)
Last 30 days (2450)
Last 365 days (32094)
2025 (4948)
2024 (32917)
2023 (37479)
2022 (48284)
2021 (52257)
2020 (51139)
2019 (44963)
2018 (34180)
2017 (31036)
2016 (30044)
2015 (34811)
2014 (26682)
2013 (22281)
2012 (23937)
2011 (24526)
2010 (22490)
Location
Africa (785)
Arizona (186)
Asia (37422)
Australia (6412)
California (4365)
Canada (1574)
China (407)
Colorado (204)
Connecticut (223)
Europe (83644)
Florida (704)
Georgia (152)
Illinois (467)
Indiana (268)
Maryland (735)
Massachusetts (3368)
Michigan (182)
Minnesota (298)
New Jersey (1302)
New York (1280)
North Carolina (824)
Northern California (1902)
Ohio (162)
Pennsylvania (1013)
South America (1079)
Southern California (1661)
Texas (671)
Utah (142)
Washington State (423)
621,285 Results for "ra medical systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024
November 18, 2024
·
5 min read
Press Releases
Verastem Oncology Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers
January 23, 2025
·
13 min read
Press Releases
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
February 12, 2025
·
13 min read
Business
Ra Medical Systems Announces First Quarter 2023 Results
Ra Medical Systems, Inc. announced financial and company highlights for the first quarter ended March 31,2023.
June 2, 2023
·
12 min read
Drug Development
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca, Inc. announced it has entered into exclusive license agreements for two preclinical RAS programs—a potential best-in-class pan-RAS molecular glue and a potential first-in-class pan-KRAS inhibitor —and provided a pipeline update.
May 16, 2024
·
10 min read
Press Releases
LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)
January 23, 2025
·
3 min read
Press Releases
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines
March 3, 2025
·
14 min read
Press Releases
Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio
December 3, 2024
·
13 min read
Press Releases
Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
October 25, 2024
·
10 min read
Press Releases
FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
January 28, 2025
·
11 min read
1 of 62,129
Next
